Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Question Reverse Split and shares for merger

Do you realize that the CEO of the company addressed this issue in one of his own Letters to the Shareholders? Are you suggesting to him as well to refrain from references to that? If a newbie is going to be looking at this stock, they are going to see the CEO raise this issue before they see the Agoracom posters raise it. If in fact they don't do just the basic DD it would take to see the CEO address it, then do you think that's the type of investor that is going to hold to help the share price rise, or just a flipper looking for a quick buck?

Share
New Message
Please login to post a reply